Search Results for "Clindamycin Hydrochloride"

09:49 EDT 25th October 2016 | BioPortfolio

Matching Channels


Syphilis is a sexually transmitted disease caused by the spirochetal bacteria Treponema pallidum subspecies pallidum. The primary route of transmission of syphilis is through sexual contact however ...

Matching News

Mylan Launches Generic Cleocin® Solution

HERTFORDSHIRE, England and PITTSBURGH, June 3, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Clindamycin Palmitate Hydroc...

FDA Approves Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) Capsules with Abuse-Deterrent Properties for the Management of Pain

Friday, August 19, 2016 -- Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) extend...

Pfizer Announces FDA Advisory Committees’ Recommend ALO-02 (oxycodone hydrochloride and naltrexone hydrochloride) Extended-Release Capsules for Approval

Wednesday, June 8th 2016 at 11:15pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) Anesthetic and Analgesic Drug Pro...

Transplacental passage of clindamycin from mother to neonate

HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions

AAPS PharmSciTech: Erratum to: Transfersomal Nanoparticles for Enhanced Transdermal Delivery of Clindamycin

Type: ErratumNo abstract available.

Hospira Recalls One Lot of Bupivacaine Hydrochloride Injectables

NewsHospira issues a voluntary nationwide recall for one lot of 0.25% Bupivacaine Hydrochloride Injection, USP due to the presence of particulate matter within a single vial.

Allergan, Adamas announce new Namzaric dosage strengths availability

David Salazar Namzaric is a fixed-dose combination of memantine and 10 mg donepezil hydrochloride indicated to treat moderate to severe Alzheimer’s disease in patients stabilized on 10 mg of do...

Matching PubMed Articles

Evaluation of Different Oral Formulations of Clindamycin Extended Release in Dogs.

The purpose of this study was to evaluate the pharmacokinetics of extended-release formulations (ERFs) of clindamycin with polymeric-based matrices. In a crossover study, 21 healthy adult dogs were ra...

Enhanced efficacy of clindamycin hydrochloride encapsulated in PLA/PLGA based nanoparticle system for oral delivery.

Clindamycin hydrochloride (CLH) is a clinically important oral antibiotic with wide spectrum of antimicrobial activity that includes gram-positive aerobes (staphylococci, streptococci etc.), most anae...

Sequential Parenteral to Oral Clindamycin Dosing in Pediatric Musculoskeletal Infection: A Retrospective Review of 30mg/kg/day vs 40mg/kg/day.

Children with musculoskeletal infection in MRSA prevalent communities are often treated with oral clindamycin. Current guidelines recommend approximately 40 mg/kg/day for MRSA infections. This study...

Transplacental passage of clindamycin from mother to neonate.

To evaluate maternal and neonatal cord blood levels at delivery in patients receiving 900 mg of clindamycin intravenous (IV) every 8 h.

Determination of the Mutant Prevention Concentration and the Mutant Selection Window of Topical Antimicrobial Agents against Propionibacterium acnes.

Determination of the mutant prevention concentration (MPC) and the mutant selection window (MSW) of antimicrobial agents used to treat pathogenic bacteria is important in order to apply effective anti...

Search Whole site using Google

Quick Search
Advertisement Advertisement